The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty

Journal of Arthroplasty

Volumn 28, Issue 7, 2013, Pages 1080-1083

  Wind, Tyler C ^a   Barfield, William R ^b,c   Moskal, Joseph T ^a  

^a CARILION CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Department of Teacher Education and Department of Sociology and Anthropology   (United States)

Author keywords

Blood loss; Hematocrit; Total knee arthroplasty; Tranexamic acid; Transfusion rate

Indexed keywords

TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; HEMATOCRIT; HOSPITAL DISCHARGE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; RECOVERY ROOM; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TOTAL KNEE REPLACEMENT;

BLOOD LOSS; HEMATOCRIT; TOTAL KNEE ARTHROPLASTY; TRANEXAMIC ACID; TRANSFUSION RATE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; FEMALE; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TRANEXAMIC ACID;

EID: 84880701454     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.11.016     Document Type: Article

References (25)

1. Bong M.R., Patel V., Chang E., et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004, 19:281.
2. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2.
3. Goodnough L.T., Verbrugge D., Marcus R.E. The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for post-operative blood salvage and reinfusion. Am J Knee Surg 1995, 8:83.
4. Freedman J., Luke K., Monga N., et al. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci 2005, 33:343.
5. Shander A., Hofmann A., Ozawa S., et al. Activity-based Costs of Blood Transfusions in Surgical Patients at Four Hospitals. Transfusion 2010, 50(4):753.
6. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31:529.
7. Dunn C.J., Goa K.L. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999, 57:1005.
8. Engel J.M., Jojaus T., Ruwoldt R., et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001, 92:775.
9. Eubanks J.D. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010, 92:775.
10. Andersson L., Nilsoon I.M., Nilehn J.E., et al. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol 1965, 2:230.
11. Dubber A.H., McNicol G.P., Douglas A.S. Amino methyl cyclohexane carboxylic acid (AMCHA): a new synthetic fibrinolytic inhibitor. Br J Haematol 1965, 11:237.
12. Boylan J.F., Klinchk J.R., Sandler A.n. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996, 85:1043.
13. Mongan P.D., Brown R.S., Thwaites B.K. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anaesth Analg 1998, 87:258.
14. Wellington K., Wagstaff A.J. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003, 63:1417.
15. Alshryda S., Sarda P., Sukeik M., et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011, 93-B:1577.
16. Wu L.D., Chen W.P., Yang Z.G. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012, 94:1153.
17. Wong J., Abrishami A., El Behiery H. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Joint Surg Am 2010, 92:2503.
18. Charoencholvanich K., Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011, 469:2874.
19. Ralley F.E., Berta D., Binns V., et al. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010, 468:1905.
20. Kakar P.N., Gupta N., Govil P., et al. Efficacy and safety of tranexamic acid in control of bleeding following TKR: a randomized clinical trial. Indian J Anaesth 2009, 53(6):667.
21. Sepah Y.J., Umer M., Ahmad T., et al. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg Res 2011, 6:22.
22. Onadera T., Majima T., Sawaguchi N., et al. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 2012, 27:105.
23. Maniar R.N., Kumar G., Singhi T., et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012, 10.1007/s11999-012-2310-y.
24. Kim H.J., Fraser M.R., Kahn B., et al. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2012, 94:1160.
25. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010, 376:23. CRASH-2 trial collaborators.